Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Private Third-Party Audits Could Enhance FDA’s Manufacturing Risk Analysis

This article was originally published in The Tan Sheet

Executive Summary

Private and third-party audits could direct FDA to problematic facilities while easing some inspection burden on firms that already comply, but not replace FDA’s typical inspection duties.
Advertisement

Related Content

Collaboration On Foreign Inspections Helps FDA Improve Resource Allocations
Collaboration On Foreign Inspections Helps FDA Improve Resource Allocations
Collaboration On Foreign Inspections Helps FDA Improve Resource Allocations
FDA Becomes An Agency Of “Directorates” Under Hamburg’s Reorganization
FDA Global Pharma Safety Plan Looks To Food Model
FDA-EMA-TGA Joint Inspection Program To Be Permanent; Other Collaborations Expand
FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan
FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan
FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model

Topics

Advertisement
UsernamePublicRestriction

Register

PS105202

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel